The First Overseas Research Conference on Medical Devices
5month14day after tomorrow17Today, with “Innovative Technology · Leading the Future " themed, lasting4day87China International Medical Devices Expo (abbreviation:CMEF) successfully concluded at the Shanghai National Convention and Exhibition Center. This sessionCMEFGathered nearly the entire domestic and international industrial chain5000Home exhibitors showcased tens of thousands of cutting-edge products, with over a thousand academic experts and opinion leaders participating in nearly a hundred sessions.MEDCONGRESSAcademic forums have become a frontier for trend dissemination and opinion collision, including various medical institutions, distributors, and more.22Ten thousand industry professionals attended the event for business exchanges and cooperation talks. Relying on top-notch resources, this event is nearly32The ten-thousand-square-meter grand event, "Aircraft Carrier," showcased the strong vitality of a comprehensive economic recovery and the surging momentum of the medical device industry to the entire industry and society in Shanghai, this capital of science and innovation, with its bustling live effects.
In the era of the pandemic, due to considerations for public health and personal well-being, public acceptance and awareness of medical devices have been widely enhanced. The overseas exploration for gold for Chinese medical device companies has quietly begun, with a plethora of manufacturers offering a diverse range of products. With the arrival of the post-pandemic era, global markets and patient needs continue to change. How to take effective actions in response to the current situation is a question that every company seeking a second growth curve must face. To help many customers resolve these doubts, Frost & Sullivan, Junlian Capital,IMQDe Kai,CSAThe First Overseas Research Conference on Medical Devices, with the support of Dahongyi, is5month15The event was successfully held on the day
This conference focused on the entire process of medical device going global, including how to empower R&D with digital and intelligent cloud services, how to effectively conduct overseas clinical trials, an in-depth yet easy-to-understand analysis of regulatory policies and access paths for different destinations and products, and trend analysis in the internationalization process of enterprises. It provided industry practitioners with the clearest roadmap for going global at present.
The meeting is chaired by Dr. Huang Jinglu, Vice President of Investment at Junlian Capital, and will be divided into10Theme of the event1At the roundtable forum, guests took turns to share and discuss. Frost & SullivanFrost & Sullivan,hereinafter referred to as 'Frost & Sullivan' Mao Hua, Partner and Managing Director of Greater China, was invited to deliver a keynote speech on "The Current Situation and Development Trends of Medical Devices Going Global in China" and participate in the roundtable forum titled "Discussing the Development Opportunities of Medical Devices Going Global".
Partner and Managing Director, Greater China, Frost & Sullivan fattening
Mao Hua interpreted the globalization of the medical device market from a capital perspective. Through the analysis of multiple dimensions of the industry, the current situation and development trends of the entire chain of medical device exports were presented to the participants, as well as an overview of Chinese medical devicesLicense-out of the MainlandThe current situation has been summarized and sorted out. He said, A larger overseas market will gradually become an important strategic layout for domestic medical device companies.
Judging from current data, the proportion of overseas sales of global leading medical device companies is much higher than that of domestic players. AbroadTop 5Medical device enterprise2022Annual income exceeds50%From overseas, and ChinaTop 5In addition to Jiuan Medical Devices, the products of other medical device companies are mainly sold domestically. Mao Hua believes that if domestic medical device companies want to become global leaders, they should consider overseas markets as an important strategic development layout for their enterprises.
On the one hand, The full normalization of centralized procurement is inevitable. The normalization of centralized procurement squeezes profit margins, and the product prices of many brands fall on the same level. Enterprises will face the dual dilemma of significant profit compression and more intense competition. Against this backdrop, Adjusting business layout and emphasizing overseas markets may bring new profit growth points to the enterprise; on the other hand, in recent years The state has continuously introduced favorable policies to promote the development of innovative medical devices, continuously enhancing the R&D capabilities of enterprises, further strengthening their overseas competitiveness, and making the industry increasingly mature.
Mao Hua pointed out that driven by the epidemic, China's medical device exportsIVDWith the proportion increasing, domestic high-end medical devices are gradually gaining international recognition. Currently, it is an excellent time for Chinese medical device companies to go global. Enterprises need to conduct thorough research on the market capacity and related data in overseas regions, choose the right outbound model and region based on their own circumstances, and implement localization execution strategies; they should also do a good job in product positioning analysis and market analysis, make strategic layouts for the entire lifecycle of products, adhere to long-termism and a global perspective, and build a systematic and international business system.
Swipe left and right to view more photos from the event
After experts from various fields shared and discussed the business scenarios of medical devices going global, the conference kicked off the roundtable forum session titled 'Discussing Development Opportunities for Medical Devices Going Global'.
Mao Hua & Junlian Capital's Managing Director, Zhou Min, and Puren SecuritiesCEOMeng Zhu, Li Jian, Chief Medical Industry Director of Amazon Web Services Greater China, and Luo Shan, Marketing Director of the National Innovation Center, Views and insights are expressed on the issues encountered by medical device-related enterprises in their overseas expansion, including capital, R&D, access, regulation, and market aspects. At the same time, active discussions are held on how to enhance product global competitiveness and achieve sustainable development under the current industry development trend.
At the same time, at the conference site, the guests also answered questions from the participants regarding business issues and trend judgments in the practical operation of medical device products going global.
About Frost & Sullivan's Healthcare Practice
The Healthcare Practice of Frost & Sullivan has professional analytical capabilities and extensive project experience in the life sciences field. Leveraging the global think tank resources of Frost & Sullivan and its cross-industry business development platform in Greater China, Frost & Sullivan Healthcare has unique core advantages in healthcare industry investment and financing services. Frost & Sullivan Healthcare has a wide range of corporate clients in China and in the past20In the year, a vast customer network was established, and a wealth of project experience in various medical sub-fields was accumulated.
Project types include Knowledge Center projects (in-depth content, promotional activities).Pre-IPO financingprojectDCF modelValuation, Business Plan Services),IPO listingWe provide listed projects (industry consulting, clinical audits, fundraising and investment writing), market research, market value management and strategic consulting. We also cooperate with well-known domestic and international information platforms and investment and financing institutions, offering one-stop solutions for enterprises in specialized fields such as pharmaceuticals and medical devices, which has attracted widespread attention from investors.
